Department of Pharmacy, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China.
Biomacromolecules. 2021 Aug 9;22(8):3149-3167. doi: 10.1021/acs.biomac.1c00440. Epub 2021 Jul 6.
The application of nanoparticles in the diagnosis and treatment of diseases has undergone different developmental stages, but phagocytosis and nonspecific distribution have been the main factors restricting the transformation of nanobased drugs into clinical practice. In the past decade, the design of membrane-coated nanoparticles has gained increasing attention. It is hoped that the combination of the cell membrane's natural biological properties and the functional integration of synthetic nanoparticle systems can compensate for the shortage of traditional nanoparticles. The membrane coating gives the nanoparticles unique biological functions such as immune evasion and targeting capability. However, when the encapsulation of monotypic membranes does not meet the diverse demands of biomedicine, the combination of different cell membranes may offer more possibilities. In this review, the composition, preparation, and advantages of biomimetic nanoparticles coated with hybrid cell membranes are summarized, and the applications of hybrid membrane-coated biomimetic nanoparticles (HM@BNPs) in drug delivery, phototherapy, liquid biopsy, tumor vaccines, immune therapy, and detoxification are reviewed. Finally, the current challenges and opportunities with regard to HM@BNPs are discussed.
纳米颗粒在疾病的诊断和治疗中的应用经历了不同的发展阶段,但吞噬作用和非特异性分布一直是限制基于纳米的药物向临床转化的主要因素。在过去的十年中,膜包覆的纳米颗粒的设计受到了越来越多的关注。人们希望细胞膜的天然生物特性与合成纳米颗粒系统的功能整合相结合,可以弥补传统纳米颗粒的不足。膜涂层赋予了纳米颗粒独特的生物功能,如免疫逃逸和靶向能力。然而,当单型细胞膜的封装不能满足生物医学的多样化需求时,不同细胞膜的组合可能会提供更多的可能性。本文总结了具有混合细胞膜的仿生纳米颗粒的组成、制备和优点,并综述了混合膜包覆仿生纳米颗粒(HM@BNPs)在药物传递、光疗、液体活检、肿瘤疫苗、免疫治疗和解毒方面的应用。最后,讨论了 HM@BNPs 当前面临的挑战和机遇。